Previous Close | 42.21 |
Open | 42.30 |
Bid | 42.21 x 100 |
Ask | 42.51 x 100 |
Day's Range | 41.24 - 42.50 |
52 Week Range | 38.43 - 67.66 |
Volume | |
Avg. Volume | 420,322 |
Market Cap | 2.072B |
Beta (5Y Monthly) | 0.85 |
PE Ratio (TTM) | 14.56 |
EPS (TTM) | 2.91 |
Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 63.25 |
Detailed Analysis of Amphastar Pharmaceuticals Inc's Q1 2024 Financial Performance
Amphastar Pharmaceuticals ( NASDAQ:AMPH ) First Quarter 2024 Results Key Financial Results Revenue: US$171.8m (up 23...
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 9, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, and Dan Dischner SVP of Corp. Communication, will participate in an Analyst-Moderated fireside chat at the Bank ...